Theoretical understanding of evolutionary dosing following tumor dynamics

M. A. Masud, Eunjung Kim

Type: Article

Publication Date: 2024-01-09

Citations: 2

DOI: https://doi.org/10.1016/j.chaos.2024.114451

View Publication

Locations

Chaos Solitons & Fractals - View

Similar Works

Action	Title	Year	Authors
+ PDF Chat	Darwinian Approaches for Cancer Treatment: Benefits of Mathematical Modeling	2021	Sophia Belkhir Frédéric Thomas Benjamín Roche
+	Optimal chemotherapy counteracts cancer adaptive resistance in a cell-based, spatially-extended, evolutionary model	2022	Matteo Italia Fabio Dercole Roberto Lucchetti
+	Optimal drug treatment for reducing long-term drug resistance	2022	Tina Ghodsi Asnaashari Young Hwan Chang
+ PDF Chat	Population Dynamics of Hybrid State during Adaptive Therapy in Cancer	2021	Ghanendra Singh
+	Combining Evolution and Cancer Therapy: A Review of the Mathematical Approach	2021	Srikanth Raghavendran Stalin Selvaraj Sruthi Suresh
+ PDF Chat	Optimal drug treatment for reducing long-term drug resistance	2022	Tina Ghodsi Asnaashari Young Hwan Chang
+ PDF Chat	A Mathematical Framework for Comparison of Intermittent versus Continuous Adaptive Chemotherapy Dosing in Cancer	2024	Cordelia D. McGehee Yoichiro Mori
+ PDF Chat	A Review of Mathematical Models for Tumor Dynamics and Treatment Resistance Evolution of Solid Tumors	2019	Anyue Yin Dirk Jan A. R. Moes J. G. Coen van Hasselt Jesse J. Swen Henk‐Jan Guchelaar
+	Tumour growth and drug resistance: an evolutionary view with perspectives in therapeutics	2016	Jean Clairambault Luís Almeida Rebecca H. Chisholm Tommaso Lorenzi Alexander Lorz Benoı̂t Perthame Camille Pouchol Emmanuel Trélat
+	A survey of open questions in adaptive therapy: Bridging mathematics and clinical translation	2023	Jeffrey West Fred Adler Jill Gallaher Maximilian Strobl Renee Brady‐Nicholls Joel S. Brown Mark Roberson-Tessi Eunjung Kim Robert Noble Yannick Viossat
+	A mathematical framework for comparison of intermittent versus continuous adaptive chemotherapy dosing in cancer	2024	Cordelia D. McGehee Yoichiro Mori
+ PDF Chat	Cell population heterogeneity and evolution towards drug resistance in cancer: Biological and mathematical assessment, theoretical treatment optimisation	2016	Rebecca H. Chisholm Tommaso Lorenzi Jean Clairambault
+	A survey of open questions in adaptive therapy: bridging mathematics and clinical translation	2022	Jeffrey West Fred Adler Jill Gallaher Maximilian Strobl Renee Brady‐Nicholls Joel S. Brown Mark Robertson‐Tessi Eunjung Kim Robert Noble Yannick Viossat
+ PDF Chat	Spatial heterogeneity and evolutionary dynamics modulate time to recurrence in continuous and adaptive cancer therapies	2017	Jill Gallaher Pedro M. Enríquez‐Navas Kimberly A. Luddy Robert A. Gatenby Alexander R.A. Anderson
+	Spatial Heterogeneity and Evolutionary Dynamics Modulate Time to Recurrence in Continuous and Adaptive Cancer Therapies	2018	Jill Gallaher Pedro M. Enríquez‐Navas Kimberly A. Luddy Robert A. Gatenby Alexander R.A. Anderson
+	Optimal control of two cytotoxic drug maximum tolerated dose steers and exploits cancer adaptive resistance in a cell-based framework	2022	Matteo Italia Fabio Dercole
+	The logic of containing tumors	2020	Yannick Viossat Robert Noble
+ PDF Chat	Conditional success of adaptive therapy: the role of treatment-pausing thresholds revealed by mathematical modeling	2025	Lanfei Sun Haifeng Zhang Kai Kang Xiaoxin Wang Leyi Zhang Yanan Cai Changjing Zhuge Lei Zhang
+ PDF Chat	An Evolutionary Perspective on Cancer, with Applications to Anticancer Drug Resistance Modelling and Perspectives in Therapeutic Control	2019	Jean Clairambault
+ PDF Chat	Adaptive Therapy For Heterogeneous Cancer: Exploiting Space And Trade-Offs In Drug Scheduling	2017	Jill Gallaher Pedro M. Enríquez‐Navas Kimberly A. Luddy Robert A. Gatenby Alexander R.A. Anderson

Works That Cite This (2)

Action	Title	Year	Authors
+	Stackelberg Evolutionary Games of Cancer Treatment: What Treatment Strategy to Choose if Cancer Can be Stabilized?	2024	Mónica L. Salvioli Hasti Garjani Mohammadreza Satouri Mark Broom Yannick Viossat Joel S. Brown Johan Dubbeldam Kateřina Staňková
+	How to use transcriptomic data for game-theoretic modeling of treatment-induced resistance in cancer cells? A case study in patient-derived glioblastoma organoids	2022	Louise Spekking Christer Lohk Wonchul Jung Maikel Verduin Sepinoud Azimi Christopher G. Hubert Marc Vooijs Rachel Cavill Kateřina Staňková

Works Cited by This (20)

Action	Title	Year	Authors
+ PDF Chat	Tumor–Immune Dynamics Regulated in the Microenvironment Inform the Transient Nature of Immune-Induced Tumor Dormancy	2013	Kathleen P. Wilkie Philip Hahnfeldt
+ PDF Chat	Modeling Tumor Clonal Evolution for Drug Combinations Design	2016	Boyang Zhao Michael T. Hemann Douglas A. Lauffenburger
+	Nonlinear adaptive control of competitive release and chemotherapeutic resistance	2019	Paul K. Newton Yuechao Ma
+	Spatial Heterogeneity and Evolutionary Dynamics Modulate Time to Recurrence in Continuous and Adaptive Cancer Therapies	2018	Jill Gallaher Pedro M. Enríquez‐Navas Kimberly A. Luddy Robert A. Gatenby Alexander R.A. Anderson
+	Towards Multidrug Adaptive Therapy	2020	Jeffrey West You Li Jingsong Zhang Robert A. Gatenby Joel S. Brown Paul K. Newton Alexander R.A. Anderson
+ PDF Chat	Turnover Modulates the Need for a Cost of Resistance in Adaptive Therapy	2020	Maximilian Strobl Jeffrey West Yannick Viossat Mehdi Damaghi Mark Robertson‐Tessi Joel S. Brown Robert A. Gatenby Philip K. Maini Alexander R.A. Anderson
+ PDF Chat	A theoretical analysis of tumour containment	2021	Yannick Viossat Robert Noble
+ PDF Chat	Adaptive Therapy for Metastatic Melanoma: Predictions from Patient Calibrated Mathematical Models	2021	Eunjung Kim Joel S. Brown Zeynep Eroglu Alexander R.A. Anderson
+ PDF Chat	Frequency-dependent interactions determine outcome of competition between two breast cancer cell lines	2021	Audrey R. Freischel Mehdi Damaghi Jessica J. Cunningham Arig Ibrahim‐Hashim Robert J. Gillies Robert A. Gatenby Joel S. Brown
+ PDF Chat	Metronomic Chemotherapy Modulates Clonal Interactions to Prevent Drug Resistance in Non-Small Cell Lung Cancer	2021	Maryna Bondarenko Marion Le Grand Yuval Shaked Ziv Raviv Guillemette Chapuisat Cécile Carrère Marie-Pierre Montero Maïlys Rossi Eddy Pasquier Manon Carré